drug

aflibercept-mrbb

1 story · latest Oct 22, 2026

Follow aflibercept-mrbb. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jun 2024 · BLA761378
Brand: Ahzantive

Timeline

FDA approves new dosage form application for Formycon's biosimilar Ahzantive

Oct 22Regulatory decisionaflibercept-mrbb

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.